Literature DB >> 6992699

Antiviral mechanisms of action.

R A Smith, R W Sidwell, R K Robins.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 6992699     DOI： 10.1146/annurev.pa.20.040180.001355

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN： 0362-1642            Impact factor:   13.820


× No keyword cloud information.
  8 in total

1.  Antiviral screening identifies adenosine analogs targeting the endogenous dsRNA Leishmania RNA virus 1 (LRV1) pathogenicity factor.

Authors:  F Matthew Kuhlmann; John I Robinson; Gregory R Bluemling; Catherine Ronet; Nicolas Fasel; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

Review 2.  The pathogenesis of acute, latent and recurrent herpes simplex virus infections.

Authors:  R J Klein
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

3.  RNA virus error catastrophe: direct molecular test by using ribavirin.

Authors:  S Crotty; C E Cameron; R Andino
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

Review 4.  Ribavirin and inosiplex: a review of their present status in viral diseases.

Authors:  T W Chang; R C Heel
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

5.  Enhanced therapeutic efficacy of poly(ICLC) and ribavirin combinations against Rift Valley fever virus infection in mice.

Authors:  M Kende; H W Lupton; W L Rill; H B Levy; P G Canonico
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

6.  In vitro and in vivo Phlebovirus inhibition by ribavirin.

Authors:  R W Sidwell; J H Huffman; B B Barnett; D Y Pifat
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

7.  Carbon-Based Nanomaterials: Promising Antiviral Agents to Combat COVID-19 in the Microbial-Resistant Era.

Authors:  Ángel Serrano-Aroca; Kazuo Takayama; Alberto Tuñón-Molina; Murat Seyran; Sk Sarif Hassan; Pabitra Pal Choudhury; Vladimir N Uversky; Kenneth Lundstrom; Parise Adadi; Giorgio Palù; Alaa A A Aljabali; Gaurav Chauhan; Ramesh Kandimalla; Murtaza M Tambuwala; Amos Lal; Tarek Mohamed Abd El-Aziz; Samendra Sherchan; Debmalya Barh; Elrashdy M Redwan; Nicolas G Bazan; Yogendra Kumar Mishra; Bruce D Uhal; Adam Brufsky
Journal:  ACS Nano       Date:  2021-04-07       Impact factor: 15.881

Review 8.  The potential use of liposome-mediated antiviral therapy.

Authors:  W C Koff; I J Fidler
Journal:  Antiviral Res       Date:  1985-06       Impact factor: 5.970
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.